[Event Report] The 23rd Special Breakfast Meeting “Innovative Financing for Global Health”
date : 10/10/2013
According to the World Health Organization, the three major infectious diseases, HIV/AIDS, tuberculosis and malaria, cause nearly 3.25 million deaths each year around the world, and, when combined with neglected tropical diseases (NTDs), it is estimated that over 1 billion people globally are affected by some type of infectious disease. In particular, improving R&D, access, cost, and quality of pharmaceuticals and medical technologies in developing countries is a matter of great urgency. However, with sluggish provision of official development assistance from the governments of developed countries, there is now a growing movement for the private sector to work with governments and other global partners to create new funding sources and promote solutions to global health problems.
New mechanisms for cooperation that go beyond existing frameworks are necessary to accomplish sustainable resolutions to recurring and forthcoming global health issues. At this Breakfast Meeting, two innovative examples were explored. UNITAID’s Dr. Broun shared with the audience the way UNITAID supports the development of markets for pharmaceuticals and medical technologies in developing countries through its groundbreaking model that places a $1 levy on international flights that operate out of partner countries. The GHIT Fund’s Dr. Slingsby followed by speaking on the GHIT Fund’s unique partnership that has brought together the Japanese government, five Japanese pharmaceutical companies, and the Bill and Melinda Gates Foundation to drive R&D for the treatment and prevention of infectious diseases and NTDs that persist in developing countries.
■Theme
Innovative Financing for Global Health
■Speaker
-Dr. Denis Broun, Executive
Director, UNITAID
-Dr. BT Slingsby, Executive Director, GHIT Fund
■Date and Time
October 9th, 2013 8:00-9:15
■Venue
Hotel Okura Tokyo, Kensington Terrace
Normal 0 0 2 false false false EN-US JA X-NONE MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:標準の表; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:””; mso-padding-alt:0mm 5.4pt 0mm 5.4pt; mso-para-margin:0mm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.5pt; mso-bidi-font-size:11.0pt; font-family:”Century”,”serif”; mso-ascii-font-family:Century; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Century; mso-hansi-theme-font:minor-latin; mso-font-kerning:1.0pt;}
Exhibition date:2013-10-09
Top Research & Recommendations Posts
Featured Posts
-
2026-08-28
[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: November 30, 2026)
-
2026-10-06
[Registration Open] (Webinar) The 146th HGPI Seminar “How We Can Build a Society That Supports Choices Around Organ Donation: Exploring Decision-Making by Citizens and a Multi-Layered Approach Through Strategic Social Marketing” (November 9, 2026)
-
2026-10-19
[HGPI Policy Column] (No.78) — From the Blood Disorders Project “Quality of Life in Long-Term Blood Cancer Care: Insights from Canada”
-
2026-10-28
[Policy Recommendations] Driving Progress in Intractable and Rare Disease Policy Through Patient and Public Voices: Towards Redesigning Healthcare Delivery Systems Across Diagnosis (September 29, 2026)



